Hedge funds, banks, fund administrators, researchers, agencies...
Hedge Funds, Alternative Investments & Asset Managers
Many of the largest and most active credit hedge funds rely on CMA's products and services to bring clarity and transparency to OTC data.
The front office relies on CMA Quotevision™'s accurate, real-time OTC price data and intuitive query and analysis tools to gain a clear, structured view of live indicative quotes. Middle office teams use the accurate, consensus-based CDS pricing information delivered by CMA Datavision™ to improve their pricing, counterparty and risk managment processes. Our valuations platform for OTC financial instruments, CMA NAVigate™, enables buy-side financial institutions to enhance their process for valuing the OTC financial instruments they hold on their books.
Integrated solutions deliver maximum benefit
Working with our client solutions team, hedge funds and other alternative investment specialists can integrate our data directly into their internal workflows, ensuring traders, risk managers and product controllers have access to the OTC data they need, when they need it.
Instant access to high quality data enables front office professionals to make faster, better informed trading decisions. CMA can provide you with a structured view of the pricing information you receive from your trading partners, helping you assess trading opportunities more accurately and efficiently. In addition, CMA offers tools that simplify and formalise the way the front office participates in the valuation process; from passive assessment to active involvement in pricing challenges and overrides.
Access to timely accurate, independent CDS pricing data helps product control teams investigate price variances and challenge/validate prices with confidence. CMA's credible, consensus-based data is sourced from the most active investors, and can be integrated seamlessly into your internal systems and processes.
Use CMA's independent, accurate CDS prices to track counterparty, market and operational risk and identify risks proactively using our unique liquidity metrics and CDS implied ratings. Gain a more accurate view of your positions and analyse your risk exposures quickly by using our price discovery solution to feed live CDS prices into your portfolios, P&L reports and risk models. In addition, our streamlined, collaborative solution for the valuation of OTC financial instruments can help you meet the required levels of transparency and accountability with ease and confidence.
Independent price verification teams use CMA's timely end-of-day and intraday data CDS pricing data to facilitate the quick identification, investigation and reporting of price variances. Empower valuation teams with a platform for efficiently managing the mark-to-market process for OTC financial instruments. The platform's accessible, interactive environment will enable valuation teams to efficiently process valuations, assess pricing inputs, manage collaboration, and report with confidence.
Automate and formalise mark-to-market workflows for OTC financial instruments. Our transparent, consensus-based valuations process simplifies audits, increases investor confidence and enhances the firm's ability to achieve FASB and IASB level 2 status for CDS instruments.
CMA's web-based valuations tool allows users to interact securely across departments and with external third parties to achieve valuation consensus. It can provide regulatory and legal teams with an intuitive interface for assessing trade information and valuation results.
Researchers use CMA's intraday and end-of-day CDS pricing data and liquidity metrics to gain an early indication of market movement. Plus, using our clean, consistent historical CDS data, they can analyse trends and back-test trading ideas.
